OSF Saint Anthony Medical Center
5666 East State Street, Rockford, IL · Osfhealthcare · · NPI 1790739977
Published prices by procedure
Cash price is what you pay without insurance. The negotiated range spans the lowest to highest rate this hospital agreed with insurers.
| Procedure | Cash price | Gross charge | Negotiated range | Payers |
|---|---|---|---|---|
| Inj fensolvi 0.25 mg HCPCS J1951 | not published | not published | $140.71 – $492.48 | 6 |
| Inj., fibryga, 1 mg HCPCS J7177 | not published | not published | $1.24 – $4.33 | 6 |
| Inj fluphenazine hcl 1.25 mg HCPCS J2679 | not published | not published | $11.80 – $11.80 | 1 |
| Inj, focinvez, 1mg HCPCS J1434 | not published | not published | $2.55 – $8.91 | 6 |
| Inj follitropin alfa 75 iu HCPCS S0126 | not published | not published | $63.43 – $63.43 | 1 |
| Inj follitropin beta 75 iu HCPCS S0128 | not published | not published | $60.25 – $60.25 | 1 |
| Inj for ext venography CPT 36005 | $1,074.60 | $1,791.00 | $315.08 – $1,468.00 | 3 |
| Inj for mammo ductogram CPT 19030 | $787.80 | $1,313.00 | $174.32 – $1,468.00 | 3 |
| Inj, fosaprepitant (teva) HCPCS J1456 | not published | not published | $0.04 – $2.00 | 6 |
| Inj fosnetupitant, palonoset HCPCS J1454 | not published | not published | $520.59 – $1,834.62 | 7 |
| Inj, fulvestrant (fresenius) HCPCS J9394 | not published | not published | $5.48 – $94.89 | 6 |
| Inj, fulvestrant (teva) HCPCS J9393 | not published | not published | $41.67 – $145.84 | 6 |
| Inj ganirelix acetat 250 mcg HCPCS S0132 | not published | not published | $83.63 – $83.63 | 1 |
| Inj givosiran 0.5 mg HCPCS J0223 | not published | not published | $120.98 – $423.44 | 6 |
| Inj glofitamab gxbm, 2.5 mg HCPCS J9286 | not published | not published | $2,840.68 – $9,942.37 | 6 |
| Inj glycopyrrolate fres kabi HCPCS J1598 | not published | not published | $2.74 – $2.74 | 1 |
| Inj, granisetron, xr, 0.1 mg HCPCS J1627 | not published | not published | $3.19 – $13.57 | 7 |
| Inj., guselkumab, 1 mg HCPCS J1628 | not published | not published | $67.81 – $237.35 | 6 |
| Inj, hemgenix, per tx dose HCPCS J1411 | not published | not published | $3,691,450.00 – $12,920,075.00 | 6 |
| Inj. herceptin hylecta, 10mg HCPCS J9356 | not published | not published | $59.91 – $209.68 | 6 |
| Inj herzuma 10 mg HCPCS Q5113 | not published | not published | $56.02 – $196.07 | 6 |
| Inj hrt cath w/s&i nonsel p-art angrp CPT 93568 | $2,214.00 | $3,690.00 | $145.56 – $1,468.00 | 3 |
| Inj hrt cath w/s&i sel hrt ang CPT 93563 | not published | not published | $65.59 – $1,468.00 | 3 |
| Inj hrt cath w/s&i sel hrt art CPT 93564 | not published | not published | $69.97 – $1,468.00 | 3 |
| Inj hrt cath w/s&i sel left vent CPT 93565 | $1,782.00 | $2,970.00 | $50.78 – $1,468.00 | 3 |
| Inj hrt cath w/s&i sel right vent CPT 93566 | $2,262.60 | $3,771.00 | $160.02 – $1,468.00 | 3 |
| Inj human fibrinogen con nos HCPCS J7178 | not published | not published | $1.52 – $5.33 | 6 |
| Inj hydroxocobalamin IV 25mg HCPCS J3424 | not published | not published | $5.44 – $19.05 | 6 |
| Inj., ibalizumab-uiyk, 10 mg HCPCS J1746 | not published | not published | $77.68 – $271.86 | 6 |
| Inj, idacio, 1 mg HCPCS Q5144 | not published | not published | $15.96 – $15.96 | 1 |
| Inj imip 4 cilas 4 releb 2mg HCPCS J0742 | not published | not published | $4.13 – $4.13 | 1 |
| Inj, imm glob bivigam, 500mg HCPCS J1556 | not published | not published | $69.46 – $278.04 | 6 |
| Inj, immphentiv, 20 mcg HCPCS J2373 | not published | not published | $0.23 – $0.23 | 1 |
| Inj. inebilizumab-cdon, 1 mg HCPCS J1823 | not published | not published | $495.54 – $1,734.41 | 6 |
| Inj/inf neurolyt sbst spinal canal lesion 62282 CPT 62282 | not published | not published | $315.67 – $3,317.36 | 8 |
| Inj intralesional <= 7 lsn(s) CPT 11900 | $386.40 | $644.00 | $56.98 – $1,468.00 | 8 |
| Inj intralesional > 7 lsns CPT 11901 | not published | not published | $72.83 – $1,468.00 | 8 |
| Inj, invega hafyera/trinza HCPCS J2427 | not published | not published | $12.95 – $45.32 | 6 |
| Inj ivig privigen 500 mg HCPCS J1459 | not published | not published | $39.69 – $173.37 | 7 |
| Inj, ixinity, 1 i.u HCPCS J7213 | not published | not published | $1.97 – $6.91 | 6 |
| Inj. jivi 1 iu HCPCS J7208 | not published | not published | $2.66 – $9.29 | 6 |
| Inj, kovaltry, 1 i.u HCPCS J7211 | not published | not published | $1.56 – $5.47 | 6 |
| Inj, lanreotide, (cipla) 1mg HCPCS J1932 | not published | not published | $32.19 – $112.66 | 6 |
| Inj, lecanemab-irmb, 1 mg HCPCS J0174 | not published | not published | $1.34 – $4.68 | 6 |
| Inj, lenacapavir, 1 mg HCPCS J1961 | not published | not published | $22.30 – $78.04 | 6 |
| Inj levocarnitine per 1 gm HCPCS J1955 | not published | not published | $20.20 – $20.20 | 1 |
| Inj levoleucovorin nos 0.5mg HCPCS J0641 | not published | not published | $0.35 – $0.35 | 1 |
| Inj, levothyroxine, freskabi HCPCS J0651 | not published | not published | $6.96 – $24.36 | 6 |
| Inj, levothyroxine, hikma HCPCS J0652 | not published | not published | $8.48 – $8.48 | 1 |
| Inj, lovotibeglogene autotem HCPCS J3394 | not published | not published | $3,245,381.39 – $11,358,834.86 | 6 |
| Inj. lumasiran, 0.5 mg HCPCS J0224 | not published | not published | $327.72 – $1,147.00 | 6 |
| Inj., lumoxiti, 0.01 mg HCPCS J9313 | not published | not published | $23.39 – $81.88 | 6 |
| Inj luxturna 1 billion vec g HCPCS J3398 | not published | not published | $3,070.09 – $10,745.31 | 6 |
| Inj lwr xtr fscl pln blk uni w/wo image CPT 64473 | not published | not published | $693.00 – $1,468.00 | 2 |
| Inj melpha hydroch nos 50 mg HCPCS J9245 | not published | not published | $120.67 – $791.34 | 7 |
| Inj melphalan (hepzato) 1 mg HCPCS J9248 | not published | not published | $795.00 – $2,782.50 | 6 |
| Inj menotropins 75 iu HCPCS S0122 | not published | not published | $55.64 – $55.64 | 1 |
| Inj mepivacaine hcl/10 ml HCPCS J0670 | not published | not published | $2.48 – $2.48 | 1 |
| Inj., meropenem, vaborbactam HCPCS J2186 | not published | not published | $2.17 – $7.60 | 6 |
| Inj meropenem (wg crit care) HCPCS J2183 | not published | not published | $2.64 – $2.64 | 1 |
| Inj metaraminol bitartrate HCPCS J0380 | not published | not published | $1.06 – $1.06 | 1 |
| Inj, mirikizumab-mrkz, 1 mg HCPCS J2267 | not published | not published | $42.09 – $147.32 | 6 |
| Inj mogamulizumab-kpkc, 1 mg HCPCS J9204 | not published | not published | $253.47 – $887.13 | 6 |
| Inj, motixafortide, 0.25 mg HCPCS J2277 | not published | not published | $26.48 – $92.68 | 6 |
| Inj, moxifloxacin 100 mg HCPCS J2280 | not published | not published | $8.15 – $8.15 | 1 |
| Inj multihance HCPCS A9577 | $13.80 | $23.00 | $2.13 – $2.13 | 1 |
| Inj multihance multipack HCPCS A9578 | not published | not published | $1.77 – $1.77 | 1 |
| Inj naloxone hydrochloride HCPCS J2310 | not published | not published | $17.36 – $17.36 | 1 |
| Inj. naxitamab-gqgk, 1 mg HCPCS J9348 | not published | not published | $686.09 – $2,401.32 | 6 |
| Inj nephrosto/ureterogram w/img exstng access CPT 50431 | $1,461.60 | $2,436.00 | $218.24 – $2,933.00 | 8 |
| Inj, nithiodote, 3mg / 125mg HCPCS J0211 | not published | not published | $2.17 – $7.58 | 6 |
| Inj, nogapendekin pmln, 1mcg HCPCS J9028 | not published | not published | $94.60 – $331.09 | 6 |
| Inj non-compmd foam sclrsnt mlt trncl veins same leg CPT 36466 | $2,640.00 | $4,400.00 | $1,641.61 – $7,738.67 | 8 |
| Inj non-compmd foam sclrsnt sgl trncl vein CPT 36465 | $2,640.00 | $4,400.00 | $1,559.11 – $7,738.67 | 8 |
| Inj, nyposi 1 mcg HCPCS Q5148 | not published | not published | $0.89 – $3.60 | 6 |
| Inj ocrelizumab 1mg hya-ocsq HCPCS J2351 | not published | not published | $46.79 – $163.78 | 6 |
| Inj, ocriplasmin, 0.125 mg HCPCS J7316 | not published | not published | $1,029.48 – $1,029.48 | 1 |
| Inj octafluoropropane mic,ml HCPCS Q9956 | not published | not published | $31.89 – $31.89 | 1 |
| Inj ogivri 10 mg HCPCS Q5114 | not published | not published | $35.78 – $125.24 | 6 |
| Inj, olaratumab, 10 mg HCPCS J9285 | not published | not published | $50.32 – $50.32 | 1 |
| Inj, oliceridine 0.1 mg HCPCS C9101 | not published | not published | $2.15 – $2.15 | 1 |
| Inj olipudase alfa-rpcp 1mg HCPCS J0218 | not published | not published | $395.60 – $1,384.59 | 6 |
| Inj, omacetaxine mep, 0.01mg HCPCS J9262 | not published | not published | $12.36 – $12.36 | 1 |
| Inj., omadacycline, 1 mg HCPCS J0121 | not published | not published | $4.13 – $14.47 | 6 |
| Inj onase abepar-xioi treat HCPCS J3399 | not published | not published | $2,587,087.26 – $9,054,805.40 | 6 |
| Inj ontruzant 10 mg HCPCS Q5112 | not published | not published | $29.81 – $104.33 | 6 |
| Inj, palonosetron (posfrea) HCPCS J2468 | not published | not published | $55.29 – $193.51 | 6 |
| Inj, panzyga, 500 mg HCPCS J1576 | not published | not published | $73.83 – $258.40 | 6 |
| Inj, pasireotide long acting HCPCS J2502 | not published | not published | $596.30 – $2,087.05 | 6 |
| Inj., patisiran, 0.1 mg HCPCS J0222 | not published | not published | $100.90 – $353.14 | 6 |
| Inj, pedmark, 100 mg HCPCS J0208 | not published | not published | $95.45 – $334.07 | 6 |
| Inj, pegcetacoplan, 1mg HCPCS J2781 | not published | not published | $147.81 – $517.32 | 6 |
| Inj pegfilgrastim-bmez 0.5mg HCPCS Q5120 | not published | not published | $40.77 – $418.73 | 6 |
| Inj, pegulicianine, 1 mg HCPCS A9615 | not published | not published | $37.51 – $131.28 | 6 |
| Inj. pemetrexed, 10 mg HCPCS J9304 | not published | not published | $7.99 – $76.48 | 6 |
| Inj pemetrexed (accord) 10mg HCPCS J9296 | not published | not published | $9.66 – $33.80 | 6 |
| Inj, pemetrexed (avyxa) 10mg HCPCS J9292 | not published | not published | $82.02 – $287.07 | 6 |
| Inj pemetrexed ditromethamin HCPCS J9323 | not published | not published | $17.06 – $17.06 | 1 |
| Inj pemetrexed, hospira 10mg HCPCS J9294 | not published | not published | $5.20 – $18.19 | 6 |
| Inj pemetrexed (teva) 10mg HCPCS J9314 | not published | not published | $10.99 – $38.45 | 6 |
A missing value means the hospital did not publish that price — it never means the price is zero. Real bills can add facility fees, supplies and professional fees; see our methodology.